Total Payments
$124,570
2024 Payments
$5,828
Companies
81
Transactions
1,449
Medicare Patients
767
Medicare Billing
$136,028
Payment Breakdown by Category
Other$85,691 (68.8%)
Food & Beverage$30,960 (24.9%)
Consulting$4,650 (3.7%)
Travel$2,963 (2.4%)
Education$306.32 (0.2%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $75,452 | 47 | 60.6% |
| Food and Beverage | $30,960 | 1,363 | 24.9% |
| Honoraria | $6,470 | 4 | 5.2% |
| Consulting Fee | $4,650 | 3 | 3.7% |
| Long term medical supply or device loan | $3,769 | 1 | 3.0% |
| Travel and Lodging | $2,963 | 19 | 2.4% |
| Education | $306.32 | 12 | 0.2% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Purdue Pharma L.P. | $45,972 | 50 | $0 (2018) |
| Depomed, Inc. | $15,179 | 35 | $0 (2017) |
| IDORSIA PHARMACEUTICALS US INC | $13,684 | 36 | $0 (2024) |
| Allergan, Inc. | $7,504 | 99 | $0 (2020) |
| ABBVIE INC. | $6,277 | 139 | $0 (2024) |
| Horizon Therapeutics plc | $4,838 | 48 | $0 (2023) |
| INTERNATIONAL REHABILITATIVE SCIENCES, INC | $3,937 | 3 | $0 (2023) |
| BioDelivery Sciences International, Inc. | $2,819 | 20 | $0 (2021) |
| AstraZeneca Pharmaceuticals LP | $2,752 | 88 | $0 (2024) |
| Amgen Inc. | $1,925 | 49 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $5,828 | 134 | IDORSIA PHARMACEUTICALS US INC ($1,602) |
| 2023 | $19,266 | 169 | IDORSIA PHARMACEUTICALS US INC ($12,057) |
| 2022 | $9,552 | 171 | Horizon Therapeutics plc ($4,524) |
| 2021 | $6,266 | 173 | AbbVie Inc. ($2,608) |
| 2020 | $8,415 | 148 | Allergan, Inc. ($6,449) |
| 2019 | $3,981 | 175 | Amarin Pharma Inc. ($653.88) |
| 2018 | $28,217 | 220 | Purdue Pharma L.P. ($24,467) |
| 2017 | $43,045 | 259 | Purdue Pharma L.P. ($21,504) |
All Payment Transactions
1,449 individual payment records from CMS Open Payments — Page 1 of 58
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/10/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $21.20 | General |
| Category: PAIN | ||||||
| 12/05/2024 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $18.87 | General |
| Category: PSYCHIATRY | ||||||
| 12/03/2024 | Axsome Therapeutics, Inc. | Auvelity (Drug) | Food and Beverage | In-kind items and services | $17.82 | General |
| Category: Psychology/Psychiatric | ||||||
| 11/28/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $30.40 | General |
| Category: NEUROSCIENCE | ||||||
| 11/21/2024 | Axsome Therapeutics, Inc. | Auvelity (Drug) | Food and Beverage | In-kind items and services | $124.66 | General |
| Category: Psychology/Psychiatric | ||||||
| 11/21/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $13.63 | General |
| Category: Respiratory | ||||||
| 11/19/2024 | Spinal Simplicity, LLC | HA MINUTEMAN G3-R (Device) | Food and Beverage | In-kind items and services | $109.38 | General |
| Category: SPINAL HARDWARE | ||||||
| 11/19/2024 | Braeburn Inc. | BRIXADI (Drug) | Food and Beverage | In-kind items and services | $18.33 | General |
| Category: Opioid Use Disorder | ||||||
| 11/16/2024 | SHIELD THERAPEUTICS INC | ACCRUFER (Drug) | Food and Beverage | In-kind items and services | $35.30 | General |
| Category: Hematology | ||||||
| 11/14/2024 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Food and Beverage | In-kind items and services | $108.85 | General |
| Category: Neuropsychiatry | ||||||
| 11/14/2024 | Teva Pharmaceuticals USA, Inc. | Austedo XR (Drug) | Food and Beverage | In-kind items and services | $19.03 | General |
| Category: Central Nervous System | ||||||
| 11/14/2024 | Teva Pharmaceuticals USA, Inc. | Austedo XR (Drug) | Food and Beverage | In-kind items and services | $1.00 | General |
| Category: Central Nervous System | ||||||
| 11/11/2024 | ABIOMED | Impella (Device) | Food and Beverage | Cash or cash equivalent | $22.95 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 10/31/2024 | ABIOMED | Impella (Device) | Food and Beverage | Cash or cash equivalent | $4.62 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 10/30/2024 | ABIOMED | Impella (Device) | Food and Beverage | Cash or cash equivalent | $122.84 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 10/30/2024 | Teva Pharmaceuticals USA, Inc. | Austedo XR (Drug) | Food and Beverage | In-kind items and services | $109.62 | General |
| Category: Central Nervous System | ||||||
| 10/29/2024 | Braeburn Inc. | BRIXADI (Drug) | Food and Beverage | In-kind items and services | $18.10 | General |
| Category: Opioid Use Disorder | ||||||
| 10/29/2024 | ABIOMED | Impella (Device) | Food and Beverage | Cash or cash equivalent | $9.91 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 10/28/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $24.50 | General |
| Category: Diabetes | ||||||
| 10/28/2024 | ABIOMED | Impella (Device) | Food and Beverage | Cash or cash equivalent | $10.24 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 10/23/2024 | Braeburn Inc. | BRIXADI (Drug) | Food and Beverage | Cash or cash equivalent | $125.00 | General |
| Category: Opioid Use Disorder | ||||||
| 10/22/2024 | Axsome Therapeutics, Inc. | Auvelity (Drug) | Food and Beverage | In-kind items and services | $20.22 | General |
| Category: Psychology/Psychiatric | ||||||
| 10/17/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $25.06 | General |
| Category: PAIN | ||||||
| 10/15/2024 | Axsome Therapeutics, Inc. | Auvelity (Drug) | Food and Beverage | In-kind items and services | $21.90 | General |
| Category: Psychology/Psychiatric | ||||||
| 10/10/2024 | Axsome Therapeutics, Inc. | Auvelity (Drug) | Food and Beverage | In-kind items and services | $8.30 | General |
| Category: Psychology/Psychiatric | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 3 | 184 | 438 | $62,545 | $33,530 |
| 2022 | 3 | 184 | 453 | $53,811 | $35,201 |
| 2021 | 3 | 181 | 436 | $49,359 | $33,490 |
| 2020 | 4 | 218 | 538 | $59,179 | $33,807 |
Total Patients
767
Total Services
1,865
Medicare Billing
$136,028
Procedure Codes
13
All Medicare Procedures & Services
13 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 99 | 237 | $39,095 | $21,839 | 55.9% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 64 | 167 | $22,328 | $11,271 | 50.5% |
| 80305 | Testing for presence of drug, read by direct observation | Office | 2023 | 21 | 34 | $1,122 | $419.90 | 37.4% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 101 | 262 | $36,680 | $24,369 | 66.4% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 61 | 157 | $16,009 | $10,407 | 65.0% |
| 80305 | Testing for presence of drug, read by direct observation | Office | 2022 | 22 | 34 | $1,122 | $424.35 | 37.8% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 78 | 218 | $30,520 | $20,705 | 67.8% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 73 | 170 | $17,255 | $12,184 | 70.6% |
| 80305 | Testing for presence of drug, read by direct observation | Office | 2021 | 30 | 48 | $1,584 | $601.32 | 38.0% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 95 | 279 | $39,060 | $22,160 | 56.7% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 75 | 183 | $17,756 | $10,635 | 59.9% |
| 80305 | Testing for presence of drug | Office | 2020 | 37 | 65 | $2,033 | $814.25 | 40.1% |
| G0008 | Administration of influenza virus vaccine | Office | 2020 | 11 | 11 | $330.00 | $197.06 | 59.7% |
About Dr. Christopher Davis, DO
Dr. Christopher Davis, DO is a Family Medicine healthcare provider based in Springfield, Pennsylvania. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 10/10/2006. The National Provider Identifier (NPI) number assigned to this provider is 1922196724.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Christopher Davis, DO has received a total of $124,570 in payments from pharmaceutical and medical device companies, with $5,828 received in 2024. These payments were reported across 1,449 transactions from 81 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($75,452).
As a Medicare-enrolled provider, Davis has provided services to 767 Medicare beneficiaries, totaling 1,865 services with total Medicare billing of $136,028. Data is available for 4 years (2020–2023), covering 13 distinct procedure/service records.
Ad
Practice Information
- Specialty Family Medicine
- Location Springfield, PA
- Active Since 10/10/2006
- Last Updated 07/08/2007
- Taxonomy Code 207Q00000X
- Entity Type Individual
- NPI Number 1922196724
Products in Payments
- SYMPROIC (Drug) $45,740
- Nucynta (Drug) $15,086
- QUVIVIQ (Drug) $13,684
- UBRELVY (Drug) $6,622
- RAYOS (Drug) $4,375
- RS 4i Plus Sequential Stimulator (Device) $3,937
- BELBUCA (Drug) $2,598
- VRAYLAR (Drug) $2,453
- QULIPTA (Drug) $2,189
- FARXIGA (Drug) $2,051
- NURTEC ODT (Drug) $1,997
- Vascepa (Drug) $1,079
- Ozempic (Drug) $949.09
- XIFAXAN (Drug) $875.80
- Repatha (Biological) $758.11
- REXULTI (Drug) $681.90
- Auvelity (Drug) $646.37
- EUCRISA (Drug) $629.97
- MOUNJARO (Drug) $582.83
- Aimovig (Biological) $525.73
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Medicine Doctors in Springfield
Stephen Adams, Md, MD
Family Medicine — Payments: $582,513
Family Medicine $582,513
Dennis Morrison, Do, DO
Family Medicine — Payments: $404,412
Family Medicine $404,412
Dr. Roger Cady, Md, MD
Family Medicine — Payments: $175,721
Family Medicine $175,721
Dr. Ali Bajwa, M.d, M.D
Family Medicine — Payments: $169,373
Family Medicine $169,373
John Wang, Do, DO
Family Medicine — Payments: $101,935
Family Medicine $101,935
Dr. William Warning, Md, MD
Family Medicine — Payments: $60,578
Family Medicine $60,578